معرفی
Arnold Vulto is a Professor at Erasmus MC in the Pharmacy department. With over 250 research publications and 18 supervised works, he is an active and influential researcher in pharmaceutical sciences. His work spans pharmacology, toxicology, and medicine with significant contributions to biosimilar research and gene therapy applications.
Professor Vulto's research primarily focuses on biosimilar agents, pharmaceutical policy, and gene therapy applications. His work bridges clinical practice, pharmacology, and healthcare economics, with particular emphasis on improving access to biologic medicines and understanding the psychological aspects of biosimilar use. His fingerprint analysis shows strong activity in Biosimilar Agents (100%), Biosimilar Medicine (83%), Medicine (32%), and Biological Products (29%).
An analysis of Professor Vulto's recent publications reveals a strong focus on biosimilar markets, patient access to biologics, and innovative gene therapy approaches for rare diseases like Pompe disease. His work combines clinical pharmacology with healthcare policy analysis, addressing both scientific and economic challenges in the pharmaceutical field. He has developed significant international collaborations, particularly with UK and Belgian stakeholders on market sustainability issues.
Professor Vulto has supervised 18 research projects, mentoring the next generation of pharmaceutical scientists and healthcare researchers. His international collaborations span multiple countries, with notable work involving UK and Belgian stakeholders on biosimilar market sustainability.
His laboratory research includes advanced work on gene therapy approaches, particularly for Pompe disease, using lentiviral vectors and proteomic analysis to understand therapeutic mechanisms at the molecular level. This research demonstrates his ability to bridge basic science with clinical applications in rare disease treatment.
